Verus Capital Partners LLC Acquires 81 Shares of Mettler-Toledo International, Inc. $MTD

Verus Capital Partners LLC raised its holdings in Mettler-Toledo International, Inc. (NYSE:MTD) by 23.1% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 431 shares of the medical instruments supplier’s stock after acquiring an additional 81 shares during the quarter. Verus Capital Partners LLC’s holdings in Mettler-Toledo International were worth $506,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. WPG Advisers LLC purchased a new stake in shares of Mettler-Toledo International during the first quarter valued at $41,000. NewSquare Capital LLC lifted its holdings in Mettler-Toledo International by 94.4% during the 2nd quarter. NewSquare Capital LLC now owns 35 shares of the medical instruments supplier’s stock valued at $41,000 after buying an additional 17 shares in the last quarter. Zions Bancorporation National Association UT purchased a new stake in Mettler-Toledo International in the 1st quarter valued at about $43,000. Sound Income Strategies LLC grew its stake in Mettler-Toledo International by 477.8% in the 2nd quarter. Sound Income Strategies LLC now owns 52 shares of the medical instruments supplier’s stock worth $61,000 after acquiring an additional 43 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd purchased a new position in shares of Mettler-Toledo International during the second quarter worth approximately $63,000. 95.07% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on MTD. Citigroup boosted their price target on Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the company a “buy” rating in a report on Monday. Barclays upped their target price on Mettler-Toledo International from $1,350.00 to $1,600.00 and gave the stock an “overweight” rating in a report on Monday. Wells Fargo & Company increased their price target on Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the stock an “equal weight” rating in a research report on Monday. Bank of America lifted their price objective on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a report on Monday, September 22nd. Finally, Stifel Nicolaus increased their target price on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the stock a “buy” rating in a report on Monday. Five analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $1,406.50.

Mettler-Toledo International Stock Performance

Shares of MTD stock opened at $1,446.25 on Wednesday. The stock’s 50-day simple moving average is $1,326.50 and its 200-day simple moving average is $1,243.39. The firm has a market capitalization of $29.79 billion, a PE ratio of 36.62, a P/E/G ratio of 4.19 and a beta of 1.41. Mettler-Toledo International, Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,462.09.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, topping analysts’ consensus estimates of $10.62 by $0.53. The firm had revenue of $1.03 billion during the quarter, compared to the consensus estimate of $997.36 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The company’s revenue was up 7.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $10.21 earnings per share. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. Sell-side analysts forecast that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Insider Buying and Selling at Mettler-Toledo International

In related news, CFO Shawn Vadala sold 300 shares of the business’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the completion of the transaction, the chief financial officer directly owned 5,095 shares in the company, valued at $6,750,875. The trade was a 5.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Gerry Keller sold 165 shares of the stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total value of $215,925.60. Following the sale, the insider directly owned 94 shares in the company, valued at $123,012.16. This represents a 63.71% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.94% of the stock is owned by corporate insiders.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.